ASCEND BY NTHRYS
Research Abroad Products

Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 2077–2088 of 2250 project topics
GIST Pharmacogenomic Risk Stratification Diagnostic Kit
A targeted sequencing panel and integrated analytics tool that predicts patient response to tyrosine kinase inhibitors based on secondary mutations and pathway alterations. This IVD product captures market share in the companion diagnostics space while generating per-test revenue from oncology centers globally.
Genomics of Gastrointestinal Stromal Tumors Click to view more details →
Federated GIST Genomic Data Network and Analytics
A decentralized platform that aggregates anonymized GIST genomic data from multiple institutions while preserving patient privacy through federated learning. This enterprise solution monetizes through data licensing, AI model development, and premium analytics access for pharmaceutical companies conducting clinical trials.
Genomics of Gastrointestinal Stromal Tumors Click to view more details →
GIST Clonal Architecture Mapping and Relapse Prediction Engine
An AI-powered software tool that reconstructs tumor clonal hierarchies from multi-region sequencing data to predict high-risk recurrence patterns in GIST patients. This platform generates revenue through licensing to hospitals and pharma, while enabling personalized adjuvant therapy recommendations that improve clinical outcomes.
Genomics of Gastrointestinal Stromal Tumors Click to view more details →
Secondary Resistance Mutation Panel Testing and Reporting
A specialized genomic testing service that rapidly identifies emerging resistance mutations in GIST patients progressing on first and second-line kinase inhibitors. This high-volume test offering creates recurring clinical laboratory revenue while supporting treatment switches that extend patient survival and increase drug prescriptions.
Genomics of Gastrointestinal Stromal Tumors Click to view more details →
iPSC Disease Model Transcriptomic Validation
Validating iPSC-derived disease models by comparing transcriptome profiles with primary tissue for confirming disease-relevant phenotypes.
Functional Genomics in Disease Models Click to view more details →
Organoid Model Genomic Characterization
Using WGS and RNA-seq for characterizing patient organoid models to confirm somatic mutations and disease gene expression signatures.
Functional Genomics in Disease Models Click to view more details →
CRISPR Disease Model Generation and Validation
Applying WGS for validating CRISPR-engineered disease models including on-target editing confirmation and off-target analysis.
Functional Genomics in Disease Models Click to view more details →
Xenograft Model Genomic Drift Monitoring
Using WGS and RNA-seq to monitor genomic evolution and gene expression changes in PDX models during passage for model quality control.
Functional Genomics in Disease Models Click to view more details →
Patient-Derived Tumor Model Genomic Profiling Platform
A cloud-based SaaS platform that sequences and analyzes patient-derived xenograft (PDX) and patient-derived organoid (PDO) models to predict drug response and tumor evolution. This enables pharmaceutical companies to accelerate preclinical drug development, reduce clinical trial failures, and monetize through subscription licensing to biotech and pharma partners.
Functional Genomics in Disease Models Click to view more details →
Disease Model Variant Annotation and Interpretation Engine
An AI-powered software tool that automatically identifies, prioritizes, and functionally annotates disease-causing variants in genomic datasets from multiple model organisms and human disease models. Revenue is generated through tiered licensing, white-label integration with CRO platforms, and per-variant analysis fees for pharmaceutical research teams.
Functional Genomics in Disease Models Click to view more details →
Multi-Omics Disease Model Biomarker Discovery Service
A managed service combining genomics, proteomics, and metabolomics profiling of disease models to identify predictive biomarkers for patient stratification and therapeutic response. This drives revenue through project-based contracts with pharmaceutical companies, biotech firms, and CROs seeking to derisk clinical development programs.
Functional Genomics in Disease Models Click to view more details →
Real-Time Disease Model Quality Control Genomics Dashboard
An enterprise monitoring platform that continuously tracks genetic stability, contamination, and authenticity across disease model populations using rapid whole-genome sequencing and real-time analytics. Customers benefit from reduced compliance risk, improved model reliability, and cost savings, creating recurring revenue through annual platform subscriptions.
Functional Genomics in Disease Models Click to view more details →